Curator Dashboard

The European Network for Translational Research in Atrial Fibrillation (EUTRAF) consortium brings together investigators aiming to accelerate knowledge in the pathophysiology and treatment of Atrial Fibrillation. By integrating the mutually complementary strengths and expertise from molecular and cellular electrophysiology to the study of large cohort of patients, EUTRAF aims to develop approaches for increasing knowledge of the arrhythmogenic substrate, with the ultimate goal of developing novel treatments and diagnostic tools.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 9,2023. Registry that archives curated nanomaterial research data and their biological and environmental implications. The Registry provides data management plans for researchers, and accepts users' public-ready data, archive them, integrate them into the registry, allowing for the data to be shared publicly. Users can request more information on specific nanomaterial records, compare multiple nanomaterials, and export data to their desktop.

• Resource
• SciCrunch
• 12 years ago - submitted by Yueling Li

Immune tolerance data management and visualization portal for studies sponsored by Immune Tolerance Network (ITN) and collaborating investigators. Data from published studies are accessible to any user; data from current in-progress studies are accessible to study investigators and collaborators. Includes links to published Figures, tools for visualization and analysis of data, and ability to query study data by subject, group, or any other study parameter.

• Resource
• SciCrunch
• 12 years ago - submitted by Yueling Li

Central data repository that supplies organisms and reagents to the broad community of microbiology and infectious diseases researchers.

• Resource
• SciCrunch
• 12 years ago - submitted by Yueling Li

The European large-scale functional genomics in the rat for translational research (EURATRANS) consortium brings together investigators who will use next-generation sequencing technologies to generate genomic, transcriptomic and epigenomic datasets. The goal is to create quantitative metabonomic and proteomic datasets to give significant depth of coverage, at multiple levels, across pathophysiological phenotypes. The aim is to enable insights into disease mechanisms, through an integrative, cross-disciplinary approach to understanding large-scale functional genomic datasets in rats and humans.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Markers for Sub-Clinical Cardiovascular Risk Assessment (EU-MASCARA) consortium aims to improve diagnosis of cardiovascular diseases and prediction of cardiovascular risk by analyzing a panel of biomarkers. EU-MASCARA aims to validate biomarkers that have been proposed to be associated with cardiovascular disease and risk across different disease entities and also in independent general population samples. The most robust biomarkers will be implemented in novel biochip based assays for clinical use.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) consortium aims to understand molecular mechanisms, diagnostics and develop novel therapeutics for epilepsy. The consortium aims to apply recent scientific breakthroughs that identified a new family of molecules that affect brain cell structure and function called microRNAs, to better understand medical products targeted to epilepsy.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium aims to translate data emerging from large-scale research efforts in molecular epidemiology into information of direct relevance to future advances in clinical medicine. The ENGAGE consortium will integrate and analyze one of the largest ever human genetics dataset (more than 80,000 genome-wide association scans and DNAs and serum/plasma samples from over 600,000 individuals). One goal is to demonstrate that the findings from ENGAGE can be used as diagnostic indicators for common diseases that will help us to understand better risk factors, disease progression and why people differ in responses to treatment.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE) consortium brings together international experts of different disciplines in an efficient and decisive collaborative network, to coordinate the response and control of an emerging new disease.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The European Clinical Research Infrastructures Network (ECRIN) is focused on synergizing and connecting the clinical research capabilities within the European continent.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Colon Therapy Research (COLTHERES) consortium brings together clinical centers and translational researchers funded in the European Union to define and perform biomarker driven clinical trials to improve cancer therapy outcomes. This 4-year consortium will use comprehensively molecularly-annotated colon cancers as a "test-bed" to define specific biomarkers of response or resistance to signaling pathway agents.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Consortium for Functional Glycomics (CFG) serves to combine the expertise and glycomics resources to reveal functions of glycans and glycan-binding proteins (GBPs) that impact human health and disease. The CFG offers resources to the community free of charge, including glycan array screening services, a reagent bank, and access to a large glycomics database and data analysis tools.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Global CEO Initiative on Alzheimer's Disease is a public- private partnership that aims to stop Alzheimer's disease and dementia. The consortium brings together international public authorities with the private sector to serve as the leading business voice on Alzheimer's disease.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Centre for Drug Safety Science (CDSS) aims to coordinate the fundamental clinical and basic research into the causes, characteristics and consequences of adverse drug reactions (ADRs). It was established as a joint venture between the Universities of Liverpool and Manchester to bring together a critical mass of knowledge and technologies in order to advance our understanding of Adverse Drug Reactions.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Clinical Decision Support (CDS) Consortium aims to enable the use of electronic health records (EHRs) to improve the safety and quality of medical care by pairing these data resources with clinical decision support systems to effectively influence physician behavior. CDS aims to advance a variety of techniques designed to facilitate and guide doctors'' decision making toward evidence‐based practice.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Centre for Drug Research and Development (CDRD) is a Canadian consortium that serves as an integrated national drug development and commercialization center. CDRD''s mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Centre for Commercialization of Regenerative Medicine''s (CCRM) is an industry consortium that aims to accelerate the application of regenerative medicine to clinical practice. Stakeholder in the consortium include the pharmaceutical, devices, reagents, tools, biomaterials and cell therapeutic companies.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Consortia Advancing Standards in Research Administration Information (CASRAI) is dedicated to reducing the administrative burden on researchers and improving business intelligence capacity of research institutions and funders.The Consortia Advancing Standards in Research Administration Information (CASRAI) aim is to improve the flow of information within and between research stakeholders by developing and maintaining a common and extensible dictionary of terms and exchangeable business objects to advance collaboration. The members include research-performing and research-funding organizations, as well as the service providers that support them. CASRAI goal is to create a central and standardized method for research teams to quickly produce any documents needed by funders and institutions. CASRAI aims to have the following outcomes: save time for researchers in applying & reporting to their funding agencies; Improve access to quality data for institutions and funders; Simplify the measurement of research impacts on society; Provide peer networking opportunities for teams tackling administrative data issues

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Collaboratory of AIDS Researchers for Eradication (CARE) is a consortium of scientific experts in the field of HIV latency from several U.S. and European academic research institutions as well as Merck Research Laboratories working together to find a cure for HIV.

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin

The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) aims to advance the safe and reliable production of biopharmaceuticals by mitigating the risk of cell culture contamination through agents such as viruses or mycoplasma, by creating a central database of accumulated industry knowledge. Currently, industrial knowledge about contaminating adventitious agents and successful approaches to combat these specific agents is largely limited to each company''s individual experience. The collection, analysis and dissemination of the full body of industry experience would enhance the reliable manufacture and supply of such safe and effective medications. This consortium operates under the umbrella of MIT Center for Biomedical Innovation (CBI).

• Organization
• Consortia-pedia, a FasterCures Project
• 12 years ago - submitted by Taylor Cronin